Vascular kallikrein in deoxycorticosterone acetate-salt hypertensive rats.

H Nolly, OA Carretero, MC Lama, R Miatello… - Hypertension, 1994 - Am Heart Assoc
H Nolly, OA Carretero, MC Lama, R Miatello, AG Scicli
Hypertension, 1994Am Heart Assoc
We determined the status of vascular kallikrein in rats with severe hypertension caused by
treatment with deoxycorticosterone acetate (DOCA) and drinking of 1% NaCl for 6 weeks.
We assayed active and total kininogenase (kallikrein) activity in the perfusate and in arterial
and venous tissue. DOCA-salt rats had higher systolic blood pressure at 6 weeks (214+/-5
mm Hg) than rats drinking tap water (135+/-4 mm Hg) or saline (145+/-8 mm Hg).
Kininogenase in the perfusate (nanograms bradykinin per minute per kilogram body weight) …
We determined the status of vascular kallikrein in rats with severe hypertension caused by treatment with deoxycorticosterone acetate (DOCA) and drinking of 1% NaCl for 6 weeks. We assayed active and total kininogenase (kallikrein) activity in the perfusate and in arterial and venous tissue. DOCA-salt rats had higher systolic blood pressure at 6 weeks (214 +/- 5 mm Hg) than rats drinking tap water (135 +/- 4 mm Hg) or saline (145 +/- 8 mm Hg). Kininogenase in the perfusate (nanograms bradykinin per minute per kilogram body weight) increased significantly at 2 weeks, from 5.8 +/- 2.1 to 8.9 +/- 1.4 for active kallikrein and from 28.7 +/- 0.4 to 48.7 +/- 2.9 for total kallikrein. Total kallikrein returned to control values at 4 weeks, whereas it was significantly reduced at 6 weeks (20.9 +/- 0.7). Active kallikrein was significantly depressed at 4 and 6 weeks (1.08 +/- 0.1 and 0.85 +/- 0.1, respectively [P < .05]). Active kallikrein in arterial tissue (picograms bradykinin per milligram per minute) showed a small but significant increase at 2 weeks, from 156 +/- 7 to 201 +/- 10 (P < .05), finally decreasing significantly by 6 weeks to 64 +/- 3; however, total kallikrein showed a significant decrease only at 6 weeks, from 844 +/- 17 to 427 +/- 27. Both active and total kallikrein in the veins were higher than control values at 2 weeks, changing from 437 +/- 7 to 541 +/- 19 and from 1619 +/- 17 to 2062 +/- 86, respectively. Venous kallikrein remained elevated until the end of the experiment.(ABSTRACT TRUNCATED AT 250 WORDS)
Am Heart Assoc